Andere talen Genovis AB

Aandelen

GENO

SE0002485979

Vertraagde tijd Nasdaq Stockholm Andere beurzen 09:53:06 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
37,45 ^SEK	+1,22%		+28,47%	-27,98%

15/05	Genovis AB (publ.) rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
14/03	Carthesian Therapeutics beëindigt licentieovereenkomst Genovis AB (publ.)	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

GenovisQ1 2024 - Financials in line with expectations, strong outlook	16/05
Interim Report January - March 2024	15/05
Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Genovis Annual Report 2023 published	24/04
NOTICE CONVENING THE 2024 ANNUAL GENERAL MEETING	09/04
Carthesian Therapeutics terminates Genovis Licence Agreement	14/03
Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	14/03
Genovis Q4 2023 - Soft ending but promising start	19/02
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Year-end report January-December 2023	15/02
Genovis AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Genovis to Get $1 Million Milestone Payment for Xork Development	13/02
Genovis to receive USD 1 million in milestone compensation related to the development of the Xork™ enzyme	13/02
Genovis AB changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11
Genovis Q3 2023 - Solid growth and profitability, Xork timeline remains on track	16/11
Genovis AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Genovis Q2 2023 - Strong growth and expanding EBIT margin	25-08-23
Half-Yearly Report January-June 2023	24-08-23
Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24-08-23
Genovis launch Innovative IgM-Specific Protease with Wide-Ranging Applications in Life Science Markets	02-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Genovis AB

Aandelen

GENO

SE0002485979

Andere talen

Filters